High-dose-rate brachytherapy boost for prostate cancer treatment: Different combinations of hypofractionated regimens and clinical outcomes.

CONCLUSIONS: The increase in BED with the hypofractionated regimens correlates with an improvement in biochemical control with of urinary toxicity. This increase in urinary toxicity is small and clinically acceptable.
PMID: 28652094 [PubMed - as supplied by publisher]

Source: Radiotherapy and Oncology : journal of the European Society for Therapeutic Radiology and Oncology - June 23, 2017 Category: Radiology Authors: Vigneault E, Mbodji K, Magnan S, Després P, Lavallée MC, Aubin S, Beaulieu L, Foster W, Martin AG Tags: Radiother Oncol Source Type: research